Glenmark Life Sciences IPO receives strong reception on 1st day: All you need to know

The initial public offering of Glenmark Life Sciences has opened for subscription and investors can bid for shares till July 29. Here is all you need to know.

The initial public offering (IPO) of Glenmark Life Sciences Limited, a subsidiary of Glenmark Pharmaceuticals, opened for subscription on Tuesday. The IPO has already got a positive reception after receiving positive feedback from analysts. The IPO will be open for subscription till July 29. Some reports suggest that the public offering has been subscribed 79 per cent on July 27 on the first day of bidding, indicating that the IPO is all set to end on a strong note.